GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Memphasys Ltd (ASX:MEM) » Definitions » YoY EPS Growth

Memphasys (ASX:MEM) YoY EPS Growth : -100.00% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Memphasys YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Memphasys's YoY EPS Growth for the quarter that ended in Dec. 2023 was -100.00%.

Memphasys's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was A$-0.00.

Memphasys YoY EPS Growth Historical Data

The historical data trend for Memphasys's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Memphasys YoY EPS Growth Chart

Memphasys Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -100.00 50.00 -100.00 - -

Memphasys Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -100.00 -100.00

Memphasys YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Memphasys's YoY EPS Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY EPS Growth (A: Jun. 2023 )
=(Earnings per Share (Diluted) (A: Jun. 2023 )-Earnings per Share (Diluted) (A: Jun. 2022 ))/ | Earnings per Share (Diluted) (A: Jun. 2022 ) |
=(-0.002--0.002)/ | -0.002 |
=0.00 %

Memphasys's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EPS Growth (Q: Dec. 2023 )
=(Earnings per Share (Diluted) (Q: Dec. 2023 )-Earnings per Share (Diluted) (Q: Dec. 2022 )) / | Earnings per Share (Diluted) (Q: Dec. 2022 )) |
=(-0.002--0.001)/ | -0.001 |
=-100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Memphasys YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Memphasys's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Memphasys (ASX:MEM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Memphasys Ltd (ASX:MEM) » Definitions » YoY EPS Growth
Comparable Companies
ASX:AVE ASX:ATX ASX:ANR ASX:ZLD ASX:TRP ASX:BTC ASX:VBS ASX:NSB ASX:BGT ASX:ILA OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
IG7:Germany
Address
30 Richmond Road, Homebush, Sydney, NSW, AUS, 2140
Website
https://www.memphasys.com
Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.

Memphasys (ASX:MEM) Headlines

No Headlines